Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Total Liabilities : ¥3,832 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co Total Liabilities?

Guizhou Bailing Group Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥3,832 Mil.

Guizhou Bailing Group Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2024 (¥3,659.13 Mil) to Dec. 2024 (¥3,935.72 Mil) but then declined from Dec. 2024 (¥3,935.72 Mil) to Mar. 2025 (¥3,832.31 Mil).

Guizhou Bailing Group Pharmaceutical Co's annual Total Liabilities increased from Dec. 2022 (¥2,898.36 Mil) to Dec. 2023 (¥4,110.29 Mil) but then declined from Dec. 2023 (¥4,110.29 Mil) to Dec. 2024 (¥3,935.72 Mil).

Guizhou Bailing Group Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co Total Liabilities Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

3,187.18

2,596.68

2,898.36

4,110.29

3,935.72

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															4,300.27	3,995.82	3,659.13	3,935.72	3,832.31

Guizhou Bailing Group Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Guizhou Bailing Group Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3799.825	+	(71.009	+	64.889
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3,936

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	7134.926	-	3199.202
	=	3,936

Guizhou Bailing Group Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3590.446	+	(171.245	+	70.622
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3,832

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	7055.82	-	3223.507
	=	3,832

Guizhou Bailing Group Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co Headlines

No Headlines